Gender and renal function influence plasma levels of copeptin in healthy individuals

Clinical Science

Volumn 116, Issue 3, 2009, Pages 257-263

  Bhandari, Sanjay S ^a   Loke, Ian ^a   Davies, Joan E ^a   Squire, Ian B ^a   Struck, Joachim ^b   Ng, Leong L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Research Department   (Germany)

Author keywords

Brain natriuretic peptide; Copeptin; Heart failure; Renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; COPEPTIN; GLYCOPEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; COPEPTINS; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT ATRIUM; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; VOLUNTEER; BLOOD; EPIDEMIOLOGY; KIDNEY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; SEXUAL DEVELOPMENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GLOMERULAR FILTRATION RATE; GLYCOPEPTIDES; HUMANS; KIDNEY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 60549098799     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080140     Document Type: Article

References (24)

1. Schrier, R. W. and Abraham, W. T. (1999) Hormones and hemodynamics in heart failure. N. Engl. J. Med. 341, 577-585
2. Hobbs, F. D. R., Davis, R. C., Roalfe, A. K. et al. (2002) Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. Br. Med. J. 324, 1498
3. Luchner, A., Hengstenberg, C., Löwel, H. et al. (2005) Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46, 118-123
4. Tsutamoto, T., Wada, A., Sakai, H. et al. (2006) Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J. Am. Coll. Cardiol. 47, 582-586
5. Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J. et al. (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 40, 976-982
6. Das, S. R., Drazner, M. H., Dries, D. L. et al. (2005) Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112, 2163-2168
7. Gegenhuber, A., Struck, J., Dieplinger, B. et al. (2007) Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J. Card. Failure 13, 42-49
8. Khan, S. Q., Dhillon, O. S., O'Brien, R. J. et al. (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115, 2103-2110
9. Morgenthaler, N. G., Struck, J., Alonso, C. et al. (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin. Chem. 52, 112-119
10. Wenzel, V., Mayr, A. J. and Hasibeder, W. R. (2003) Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 63, 237-256
11. Robertson, G. L., Mahr, E. A., Athar, S. et al. (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J. Clin. Invest. 52, 2340-2352
12. Preibisz, J. J., Sealey, J. E., Laragh, J. H. et al. (1983) Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5, 129-138
13. Stevens, L. A., Coresh, J., Feldman, H. I. et al. (2007) Evaluation of the modification of diet in renal disease study equation in a large diverse population. J. Am. Soc. Nephrol. 18, 2749-2757
14. Schiller, N. B., Shah, P. M., Crawford, M. et al. (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 2, 358-367
15. Devereux, R. B., Koren, M. J., de Simone, G. et al. (1993) Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur. Heart J. 14, 8-15
16. Guidelines Subcommittee World Health Organization/International Society of Hypertension (WHO/ISH). (1999) Guidelines for the management of hypertension. J. Hypertens. 17, 151-183
17. Omland, T., Persson, A., Ng, L. et al. (2002) N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106, 2913-2918
18. Møller, J. E., Poulsen, S. H., Søndergaard, E. et al. (2000) Preload dependence of color M-mode Doppler flow propagation velocity in controls and in patients with left ventricular dysfunction. J. Am. Soc. Echocardiogr. 13, 902-909
19. Stoiser, B., Mörtl, D., Hülsmann, M. et al. (2006) Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur. J. Clin. Invest. 36, 771-778
20. Nakamura, T., Funayama, H., Yoshimura, A. et al. (2006) Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int. J. Cardiol. 106, 191-195
21. Costello-Boerrigter, L. C., Boerrigter, G., Redfield, M. M. et al. (2006) Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J. Am. Coll. Cardiol. 47, 345-353
22. Raymond, I., Groenning, B. A., Hildebrandt, P. R. et al. (2003) The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89, 745-751
23. Sayama, H., Nakamura, Y., Saito, N. and Kinoshita, M. (1999) Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron. Artery Dis. 10, 537-540
24. Akiba, T., Tachibana, K., Togashi, K. et al. (1995) Plasma human brain natriuretic peptide in chronic renal failure. Clin. Nephrol. 44, 61-64